Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of calcifediol in postmenopausal osteoporosis
2015-005303-91Phase 4Completed
- Sponsor
- Azienda Ospedaliera Universitaria Senese
- Start
- Nov 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of calcifediol in postmenopausal osteoporosis, Metabolic osteopathies, Calcium metabolism disorders and 1 more (2 arms), sponsored by Azienda Ospedaliera Universitaria Senese. Primary endpoint: Pharmacokinetics of 25(OH)D3. Started Nov 2020; status: completed.
02
Drugs
calcifediol
03
Conditions
postmenopausal osteoporosisMetabolic osteopathiesCalcium metabolism disordersphosphorus metabolism disorder
Beyond the preview
Go deeper on 2015-005303-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005303-91.